STOCKHOLM – Mycronic announced sales of SEK5.7 billion ($543.7 million) in 2023, an increase of 11% from the previous year.

For the fourth quarter, the company saw record sales of SEK1.97 billion ($187.8 million), marking a 31% year-over-year increase.

"We ended the year strongly with an increase in net sales of 31% to the new record level of SEK1,968 million and our best ever EBIT of SEK620 million, corresponding to an EBIT margin of 32%," said president and CEO Anders Lindqvist. "Order intake was healthy, although we could not match the extremely strong order intake from the fourth quarter of the previous year."

Looking to the future, the company projects 2024 sales of of SEK6.25 billion ($596 million).

• Prev
• Next